- Imprimis Pharmaceuticals, Inc. stock price today and history
Imprimis Pharmaceuticals, Inc. (IMMY) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Imprimis Pharmaceuticals, Inc. stock price
Imprimis Pharmaceuticals, Inc. latest news:
Imprimis Pharma to take on Allergan's Restasis with cheaper product
(Reuters) - Shares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to Allergan Plc's controversial dry eye drug, Restasis, by next month.
BRIEF-Allergan USA files suits against Imprimis, Prescriber's Choice and Sincerus Florida
Allergan Plc(AGN). * Allergan(AGN) files suits against Imprimis Pharmaceuticals, Inc. (IMMY), Prescriber's Choice, Inc., and Sincerus Florida, LLC. * Says Allergan USA filed lawsuits against Imprimis Pharmaceuticals (IMMY), Prescriber's Choice, and Sincerus Florida. * Allergan USA's lawsuit alleges that the companies are unlawfully manufacturing and selling unapproved new drugs.
INC Research Holdings, Inc.INCR
Independent Bank Corp.INDB
Independent Bank CorporationIBCP
Independent Bank Group, IncIBTX
Industrial Services of America, Inc.IDSA
Infinity Pharmaceuticals, Inc.INFI
Infinity Property and Casualty CorporationIPCC